Analysis of local tumor control in Ewing's sarcoma: preliminary results of a cooperative intergroup study.
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004307:Dose-Response Relationship, Radiation; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007223:Infant; D008175:Lung Neoplasms / Q000628:therapy; D008297:Male; D009362:Neoplasm Metastasis / Q000628:therapy; D010386:Pelvic Neoplasms / Q000628:therapy; D012075:Remission, Spontaneous; D012512:Sarcoma, Ewing / Q000628:therapy*; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003609:Dactinomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide